C12N 2501/24
Interferons [ifn]
Official title: Interferons [IFN]
C12N2501/24 (Interferons [ifn]) appears on 288 US grants and 603 published applications in this corpus.
Search patents in C12N- Granted patents
- 288
- Published applications
- 603
- Assignees
- 348
- Inventors
- 1,097
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 5 | 0 |
| 1999 | 4 | 0 |
| 2000 | 3 | 0 |
| 2001 | 4 | 4 |
| 2002 | 1 | 7 |
| 2003 | 1 | 10 |
| 2004 | 5 | 17 |
| 2005 | 1 | 5 |
| 2006 | 1 | 9 |
| 2007 | 2 | 5 |
| 2008 | 6 | 10 |
| 2009 | 3 | 15 |
| 2010 | 0 | 11 |
| 2011 | 4 | 12 |
| 2012 | 5 | 10 |
| 2013 | 9 | 9 |
| 2014 | 5 | 9 |
| 2015 | 7 | 17 |
| 2016 | 10 | 21 |
| 2017 | 11 | 25 |
| 2018 | 10 | 30 |
| 2019 | 21 | 51 |
| 2020 | 17 | 40 |
| 2021 | 35 | 62 |
| 2022 | 25 | 55 |
| 2023 | 12 | 52 |
| 2024 | 32 | 50 |
| 2025 | 23 | 40 |
| 2026 | 18 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antigen presenting T cells, sensitized, manufactured T cells and methods of treatment using the same14 Jul 2026US 12,680,074 B2Rapa Therapeutics, LLC
- Methods of preserving mesenchymal stem cells16 Jun 2026US 12,653,841 B2Children's Healthcare of Atlanta, Inc.
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy16 Jun 2026US 12,655,389 B2Iovance Biotherapeutics, Inc.
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy9 Jun 2026US 12,648,962 B2Iovance Biotherapeutics, Inc.
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy2 Jun 2026US 12,642,816 B2Iovance Biotherapeutics, Inc.
- Metabolically enhanced vd1 t cells and uses thereof8 Oct 2026US 2026/0308518 A1
- Cd4+ cytotoxic t cells and methods of use thereof8 Oct 2026US 2026/0308522 A1Dana-Farber Cancer Institute, Inc.
- Single b-cell cultivation method24 Sep 2026US 2026/0285949 A1Hoffmann-La Roche Inc.
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy17 Sep 2026US 2026/0272985 A1Iovance Biotherapeutics, Inc.
- Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy17 Sep 2026US 2026/0272986 A1Iovance Biotherapeutics, Inc.
Most cited
By later US patents
- Mesenchymal stem cells for prevention and treatment of immune responses in transplantation181US 6,328,960 B1Osiris Therapeutics, Inc. · 2001
- Mesenchymal stem cells for prevention and treatment of immune responses in transplantation118US 6,875,430 B2Osiris Therapeutics, Inc. · 2005
- Mesenchymal stem cells for prevention and treatment of immune responses in transplantation103US 6,368,636 B1Osiris Therapeutics, Inc. · 2002
- Method of culturing lymphocytes and method of treatment using such lymphocytes88US 5,443,983 ARegents of the University of Minnesota · 1995
- Methods of producing membrane vesicles80US 6,812,023 B1Anosys, Inc. · 2004